CUCCURULLO, Franco
 Distribuzione geografica
Continente #
NA - Nord America 11.048
EU - Europa 8.475
AS - Asia 7.818
SA - Sud America 859
AF - Africa 91
Continente sconosciuto - Info sul continente non disponibili 17
OC - Oceania 7
Totale 28.315
Nazione #
US - Stati Uniti d'America 10.878
SG - Singapore 2.930
CN - Cina 2.631
UA - Ucraina 1.694
IE - Irlanda 1.330
TR - Turchia 1.232
SE - Svezia 1.121
GB - Regno Unito 1.078
IT - Italia 1.001
FR - Francia 740
BR - Brasile 730
DE - Germania 604
IN - India 483
FI - Finlandia 358
RU - Federazione Russa 250
VN - Vietnam 239
CA - Canada 103
PL - Polonia 77
AR - Argentina 59
MX - Messico 49
BD - Bangladesh 44
BE - Belgio 43
ES - Italia 41
ZA - Sudafrica 39
JP - Giappone 37
HK - Hong Kong 34
KR - Corea 34
CZ - Repubblica Ceca 29
IQ - Iraq 27
NL - Olanda 27
EC - Ecuador 24
IL - Israele 21
RO - Romania 20
IR - Iran 18
ID - Indonesia 16
EU - Europa 15
AT - Austria 14
GR - Grecia 14
CO - Colombia 13
LT - Lituania 12
PK - Pakistan 12
MA - Marocco 11
KE - Kenya 10
VE - Venezuela 10
EG - Egitto 9
PY - Paraguay 7
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
DZ - Algeria 6
JO - Giordania 6
CL - Cile 5
MY - Malesia 5
NO - Norvegia 5
SA - Arabia Saudita 5
TN - Tunisia 5
AU - Australia 4
AZ - Azerbaigian 4
OM - Oman 4
AL - Albania 3
BN - Brunei Darussalam 3
ET - Etiopia 3
HR - Croazia 3
KZ - Kazakistan 3
LB - Libano 3
MD - Moldavia 3
PE - Perù 3
PS - Palestinian Territory 3
PT - Portogallo 3
SR - Suriname 3
UY - Uruguay 3
AO - Angola 2
BO - Bolivia 2
CI - Costa d'Avorio 2
CU - Cuba 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
HN - Honduras 2
JM - Giamaica 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PA - Panama 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BB - Barbados 1
CR - Costa Rica 1
EE - Estonia 1
GD - Grenada 1
GE - Georgia 1
KG - Kirghizistan 1
KI - Kiribati 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
ML - Mali 1
MO - Macao, regione amministrativa speciale della Cina 1
NI - Nicaragua 1
PH - Filippine 1
PR - Porto Rico 1
QA - Qatar 1
Totale 28.309
Città #
Singapore 2.135
Jacksonville 1.808
Chandler 1.588
Dublin 1.317
Southend 777
Izmir 655
Princeton 636
Beijing 605
Dallas 520
Nanjing 501
Ashburn 483
Dearborn 418
Wilmington 373
Los Angeles 320
Cambridge 301
Tongling 245
The Dalles 239
Chieti 222
Santa Clara 222
Ann Arbor 212
Nanchang 192
Woodbridge 167
New York 163
Buffalo 162
Altamura 149
Boardman 135
Shenyang 98
Ho Chi Minh City 88
Tianjin 83
Council Bluffs 80
Hebei 80
Munich 80
Jiaxing 77
Houston 73
São Paulo 73
Grevenbroich 68
Hefei 62
Washington 62
Kunming 60
San Mateo 53
Warsaw 49
Brooklyn 47
Changsha 46
Hangzhou 43
Brussels 41
Milan 41
Augusta 39
Jinan 38
Hanoi 37
Tokyo 37
Auburn Hills 36
Orange 36
Toronto 35
Hong Kong 34
Redondo Beach 34
Stockholm 34
Dong Ket 33
Montreal 33
Helsinki 32
Johannesburg 32
Leawood 32
Rome 32
Norwalk 31
Chennai 30
Seoul 30
Denver 29
Moscow 29
Seattle 29
Pescara 28
Rio de Janeiro 28
Chicago 27
Guangzhou 27
Ningbo 27
Brno 26
Turku 24
London 23
Phoenix 21
Poplar 21
Atlanta 20
Orem 20
Falls Church 19
Boston 18
Kraków 18
Manchester 18
Tappahannock 18
Zhengzhou 17
Changchun 16
Mexico City 16
Lanzhou 15
Querétaro 15
San Francisco 15
Taizhou 15
Amsterdam 14
Belo Horizonte 13
Frankfurt am Main 13
Hanover 13
Mumbai 13
Ardabil 12
Curitiba 12
Montesilvano 11
Totale 17.174
Nome #
Rimodellamento concentrico del ventricolo sx in pazienti con ipertensione essenziale: è un pattern geometrico omogeneo? 247
Ouabaina endogena, pattern emodinamico e geometria ventricolare sx nell'ipertensione essenziale. 196
13C Breath tests and cytosolic liver function. 167
Ascorbic acid supplementation reduces oxidative stress and platelet biochemical function in type 2 diabetic patients. Relevance of ascorbic acid dosage and formulation 161
Suppression of RAGE as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes. 151
Increased expression of transforming growth factor-beta1 as a stabilizing factor in human atherosclerotic plaques. 149
Assessment of EGFR mutations in circulating tumor cell preparations from NSCLC patients by next generation sequencing: Toward a real-time liquid biopsy for treatment 149
Effective assessment of egfr mutation status in bronchoalveolar lavage and pleural fluids by next-generation sequencing. 149
Allergen immunotherapy: an effective immune-modifier. 148
48-Hour continuous pH measurement in patients with gastro-oesophageal reflux: effect of cisapride. 144
Blood cardioplegia: could it protect the ischemic-reperfused human myocardium through antioxidant-type mechanisms? 142
Effect of MK-571, a selective leukotriene D4 receptor antagonist, on vascular smooth muscle cell proliferation and interleukin 1 release 141
Aortic glutathione metabolic status: time-dependent alterations in fat-fed rabbits 140
Aortic antioxidant defence mechanisms: time-related changes in cholesterol-fed rabbits. 139
Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteases activity 138
OVEREXPRESSION OF TOLL LIKE RECEPTOR 4 AS A BASIS OF CYCLOOXYGENASE 2-DEPENDENT ATHEROSCLEROTIC PLAQUE INSTABILITY IN HUMANS. 137
Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. 137
'White-coat' hypertension in patients with newly diagnosed hypertension: evaluation of prevalence by ambulatory monitoring and impact on cost of health care 134
White-coat resistant hypertension 134
EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment. 133
Calcium homeostasis in excitable cells exposed to ELF. 129
A Polymorphism in the Cyclooxygenase 2 Gene as an Inherited Protective Factor Against Myocardial Infarction and Stroke 128
Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty. 128
Low density lipoprotein oxidation and antioxidant vitamins in dipper and nondipper hypertensive patients 127
Attività della paraoxonasi sierica in pazienti con ipertensione arteriosa essenziale. 126
Relationship between oxidative stress, monocyte activation and restenosis after coronary angioplasty. 126
Additional Antihypertensive effect of fluvastatin in hypertensive and hypercholesterolemic patients treated with trandolapril. 126
Helicobacter pylori infection causes persistent platelet activation in vivo through enhanced lipid peroxidation 126
Circadian variations in antioxidant defences and lipid peroxidation in the rat heart 125
Cardiovascular risk in patients receiving double therapy with false and true nonresponder hypertension. 125
Association between prostaglandin E receptor subtype EP4 overexpression and unstable phenotype in atherosclerotic plaques in human. 125
Sensitivity disturbances in patients with irritable bowel syndrome and fibromyalgia 125
AORTIC ANTIOXIDANT DEFENSE MECHANISMS IN RABBITS SUBJECTED TO SUPRARENAL AORTIC COARCTATION HYPERTENSION 125
Increase in CD45RO+ cells and activated eosinophils in chronic allergic conjunctivitis. 124
Myocardial glutathione metabolic status in fat-fed rabbits 123
Amiodarone inhibits tocopherol-mediated human lipoprotein peroxidation 122
Ambroxol is a scavenger of hypochlorous acid and monochloramine 122
Angiotensin-converting enzyme inhibitors counteract hypoxia-induced coronary constriction in the isolated rat heart 121
Cephalosporins are scavengers of hypochlorous acid 121
Symptoms discriminate irritable bowel syndrome from organic gastrointestinal diseases and food allergy. 121
INCREASED TYPE I AND TYPEII TRANSFORMING GROWTH FACTOR-β RECEPTOR EXPRESSION DURING CHOLESTEROL CHALLENGE. 119
Haemostatic abnormalities, cardiac involvement and serum tumor necrosis factor levels in X-linked dystrophic patients. 119
Circulating leptin is associated with oxidized LDL in postmenopausal women. 119
Transmural distribution of antioxidant defences and lipid peroxidation in the rabbit left ventricular myocardium 119
Blunted nocturnal fall in blood pressure and oxidative stress in men and women with essential hypertension. 118
Soluble thrombomodulin and vascular adhesion molecule-1 are associated to leptin plasma levels in obese patients. 118
Increased expression of transforming growth factor beta isoforms by human monocytes of hypertensive patients 118
A prospective evaluation of iron deficiency anemia in the GI endoscopy setting: role of standard endoscopy, videocapsule endoscopy, and CT-enteroclysis 117
Cigarette smoke, ferritin, and lipid peroxidation 117
High preprocedural non-HDL cholesterol is associated with enhanced oxidative stress and monocyte activation after coronary angioplasty: possible implications in restenosis. 116
Heightened free radical activity in angina pectoris 116
Association between 5-lipoxygenase expression and plaque instability in humans. 116
Metabolic Syndrome and Cardiovascular Risk in Elderly Treated Hypertensive Patients. 115
Vascular characteristic in hypertensive patients with different left ventricular morphology 114
Ossidazione delle LDL e vitamine antiossidanti in pazienti ipertesi dipper e nondipper. 114
Int6 expression can predict survival in early-stage non-small cell lung cancer patients. 114
Alterazioni della parete vescicale in bambini affetti da enuresi notturna. 113
Low density lipoprotein oxidation in white coat and sustained hypertension (pubbl. su Am J Hypertension). 113
Antioxidant metabolic mechanisms in hypertensive and atherosclerotic arterial wall 113
Association of body iron stores with low molecular weight iron and oxidant damage of human atherosclerotic plaques 113
Blood cardioplegia reduces oxidant burden in the ischemic and reperfused human myocardium 113
Paraoxonase activity is significantly reduced in smokers. Effect of vitamin E supplementation 112
Human interleukin 1 receptor antagonist (IL-1RA) inhibition of inducible thromboxane B2 generation in human monocytes 112
Study of the gastric mucosal reactivity in patients with urticaria induced by nonsteroidal anti-inflammatory drugs. 111
Reversal of P-glycoprotein-mediated multidrug resi stance in human sarcoma MES-SA/Dx-5 cells by nonsteroidal anti-inflammatory drugs 111
Ambulatory blood pressure monitoring in type 2 diabetes and metabolic syndrome: a review. 111
Cardiovascular outcome in treated hypertensive patients with responder, masked, false resistant, and true resistant hypertension. 111
Blood pressure variability and cardiovascular risk in treated hypertensive patients. 111
Effect of ischemia and reperfusion on antioxidant enzymes and mitochondrial inner membrane proteins in perfused rat heart. 110
Aortic glutathione-related antioxidant defences in rabbits subjected to suprarenal aortic coarctation hypertension 110
Antioxidant metabolic mechanisms in hypertensive and atherosclerotic arterial wall 110
Arterial Thrombosis in ambulatory cancer patients treated with chemotherapy. 110
Increased type II transforming growth factor-beta receptor expression in liver cells during cholesterol challenge 109
Cardiovascular and renal events in uncomplicated mild hypertensive patients with sustained and white coat hypertension 109
Inhibition of P-glycoprotein-mediated multidrug resistance by unfractionated heparin: a new potential chemosensitizer for cancer therapy. 109
Heparin: does it act as an antioxidant in vivo? 109
[Physiopathological bases of the medical treatment of portal hypertension]. 109
Aortic antioxidant defence mechanisms during the progression of atherosclerosis in cholesterol-fed rabbits 109
Morning blood pressure surge, dipping, and risk of ischemic stroke in elderly patients treated for hypertension 109
Microsatellite polymorphism of the human leptin gene (LEP) and risk of cardiovascular disease 108
Copper, zinc superoxide dismutase plus hydrogen peroxide: a catalytic system for human lipoprotein oxidation 108
Antiproliferative effect of deferoxamine on vascular muscle cells in vitro and in vivo. 108
Prognostic value of different indices of blood pressure variability in hypertensive patients 108
Thrombophilia and outcomes of assisted reproduction technologies: a systematic review and meta-analysis 108
Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E(2)-dependent plaque instability. 107
Effect of ischaemia-reperfusion on glutathione peroxidase, glutathione reductase and glutathione transferase activities in human heart protected by hypothermic cardioplegia. 107
Left atrial enlargement and risk of ischemic stroke in elderly treated hypertensive patients 107
Ambulatory blood pressure stage 106
PRAVASTATIN UP-REGULATES TGF-B1 IN THP-1 HUMAN MACROPHAGES :EFFECT ON SCAVENGER RECEPTOR CLASS A EXPRESSION 106
Effects of ELF-EMF exposure on haemopoiesis and mammary carcinogenesis in BALB/c mice 106
Monocyte chemotactic protein 1 (MCP-1) is a mitogen for cultured rat vascular smooth muscle cells. 106
Relationship between reduced BCL-2 expression in circulating mononuclear cells and early nephropathy in type 1 diabetes. 106
Modulation of multidrug resistance p-glycoprotein activity by flavonoids and honokiol in human doxorubicin- resistant sarcoma cells (MES-SA/DX-5): implications for natural sedatives as chemosensitizing agents in cancer therapy. 106
Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: effects of statin therapy. 105
Correspondence - In Reply - Limitations of Single-Strand Conformation Polymorphism Analysis As a High-Throughput Method for the Detection of EGFR Mutations in the Clinical Setting 105
Modulatory effects of heparin on cellular accumulation and cytotoxicity of doxorubicin in MRP1-overexpressing HL60/doxo cells. 105
Distribuzione transmurale dei sistemi antiossidanti e della perossidazione lipidica nel ventricolo sinistro di coniglio 105
Morning Blood Pressure Surge, Dipping, and Risk of Coronary Events in Elderly Treated Hypertensive Patients 105
Effect of thyroid function on systemic oxidative stress 104
Down regulation of cyclooxygenase-2 (COX-2) by interleukin-1 receptor antagonist in human monocytes. 104
Totale 12.177
Categoria #
all - tutte 112.432
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 112.432


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.183 0 0 0 0 0 404 20 8 226 303 104 118
2021/20221.408 79 20 17 315 149 16 20 104 114 37 154 383
2022/20234.241 348 509 238 548 403 885 264 290 526 50 101 79
2023/20241.783 142 65 128 46 94 532 457 62 16 43 11 187
2024/20254.745 335 810 632 58 106 156 88 216 454 211 600 1.079
2025/20264.534 884 436 944 1.211 892 167 0 0 0 0 0 0
Totale 28.774